Skip to main navigation Skip to search Skip to main content

Regional Cerebral Blood Flow Imaging with 99mTc-Bicisate SPECT in Asymmetric Parkinson's Disease: Studies with and Without Chronic Drug Therapy

  • National Institutes of Health

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Regional cerebral perfusion was assessed in six patients with asymmetric Parkinson's disease (PD) of mild to moderate severity and in six matched normal subjects using 99mTc-bicisate single photon emission computed tomography (SPECT). Regional activity was normalized to whole-brain activity. Each subject was studied twice, separated by 15.2 ± 9.2 and 18.0 ± 4.8 days in normals and PD patients, respectively. There was low intrasubject scan-rescan variability in normals, with all regions showing an average intrasubject difference in repeat studies of <3%. In PD patients after chronic oral antiparkinsonian drugs had been withdrawn, as compared with normal subjects, there was increased perfusion in the caudate and lenticular nuclei contralateral to the worst affected extremities. This increased basal ganglia perfusion was attenuated by chronic oral therapy. The clinical relevance of these changes is indicated by the high positive correlation between various measures of clinical PD severity and the lenticular perfusion. These differences in basal ganglia perfusion measured with 99mTc-bicisate SPECT in mild to moderate, asymmetric PD may be secondary to increased metabolic demand resulting from alterations of synaptic activity.

Original languageEnglish
Pages (from-to)S106-S114
JournalJournal of Cerebral Blood Flow and Metabolism
Volume14
Issue numberSUPPL. 1
StatePublished - Jan 1994

Keywords

  • Asymmetric Parkinson's disease
  • Basal ganglia perfusion
  • Ethyl cysteinate dimer
  • Single photon emission computed tomography

Fingerprint

Dive into the research topics of 'Regional Cerebral Blood Flow Imaging with 99mTc-Bicisate SPECT in Asymmetric Parkinson's Disease: Studies with and Without Chronic Drug Therapy'. Together they form a unique fingerprint.

Cite this